Dyno Therapeutics

Backed byAndreessen Horowitz
Total raised$209.0M
StageSeries A
Hiring pace3 roles / 90d
Founded2018
Team size51-200 employees
HQWatertown, Massachusetts
IndustriesBiotechnology

About Dyno Therapeutics

Dyno Therapeutics aims to build high-performance genetic technologies that transform patient lives. The company operates at the intersection of AI and genetic medicine. It unites world-class molecular biologists, protein engineers, software developers, data scientists, and machine learning experts to drive its mission. By bringing together these disciplines, Dyno Therapeutics seeks to accelerate the development of transformative genetic solutions for patients.

Open positions · 3

Location

Culture & values

Core values guiding the culture are One Mission, Proactive Responsibility, and Reaching for Excellence.

One Mission means everything the team does is for the mission, with a cohesive, motivated, and supportive team that overcomes challenges.

Proactive Responsibility means taking action, injecting energy into work, and holding oneself accountable for delivering results.

Reaching for Excellence means constantly striving for excellence, fueled by curiosity, adaptability, and the courage to speak hard truths.

The company's culture emphasizes a strong work ethic as its greatest strength.

The team is a high-energy, cross-disciplinary group including molecular biologists, protein engineers, software developers, data scientists, and machine learning experts collaborating at the AI-genetic medicine intersection.

The culture portrays its members as relentlessly resourceful problem-solvers who generate breakthroughs.

Funding History

Cumulative Funding

Life at Dyno Therapeutics

Frequently asked questions

Companies similar to Dyno Therapeutics

EVANIUM

EVANIUM is a Regensburg, Germany–based life-science startup that aims to unleash the potential of plant compounds. The company uses its OPTISOLV platform to transform plant extracts into highly water-soluble, stable ingredients, serving customers in Germany and the USA and drawing international interest from Korea and beyond. With a 12-person team, EVANIUM has raised 2.2 million euros in seed funding led by Foodlabs and Phis, with investors including Böhringer Ingelheim and Razorfarm, and has earned an award at Vitafood. This year the company reported 350,000 euros in revenue and produced 2.5 tons of raw material, positioning itself as an innovative player in the plant-based ingredient market.

Biotechnology1-10
9 Mothers

9 Mothers Defense develops fast and cost-effective counter-small UAS (C-sUAS). The company uses AI for detection, tracking and defensive systems to protect against aerial threats, building AI-powered machines designed to intercept and neutralize Group 1/sUAS threats in real time. Operating in the defense industry with a focus on immediate threat countermeasures, it pursues mission-critical work countering immediate real-world aerial threats. Meaningful early equity for foundational owners and direct roadmap influence give employees a seat at the table shaping product and technology trajectory from day one, with zero red tape allowing them to make technical decisions autonomously. An on-site team in Austin, Texas builds robots, sensors and models to control them from scratch, using Python and Rust on embedded hardware, and their work spans vision, acoustics, radar and control systems across hardware and software.

Aerospace and Defense
Aira

Aira is an AI platform designed for procedural specialties that serves as the payer intelligence layer for medical device companies and surgical practices. The company automates critical back-office workflows while handling the full payer compliance lifecycle, including benefits verification, medical necessity determinations, prior authorization, and appeals management. By functioning as the intelligence layer powering market access teams, Aira helps healthcare providers and device manufacturers navigate the complexity of reimbursement processes to increase patient access to needed procedures. The platform addresses a key pain point in healthcare operations by streamlining the administrative burden that often delays care and complicates market entry for medical innovations.

HealthTech1-10